# A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period

> **NCT02587195** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 5 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Teriflunomide

## Key facts

- **NCT ID:** NCT02587195
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-18
- **Primary completion:** 2020-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587195, "A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02587195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*